Query:Click here

BFSRI/Tinami Cancer Clinic

Advanced Research and Therapy for Cancers

 We use autologous cancer antigen pulsed adoptive immune-cells therapy, oncogene targetting therapy and herbal supplement therapy. 

 

Principles

1. We aim "never give up recovery even from the end-stage of cancer". 

2. We never use non-effective therapeutics by  monitoring and assessment.

3. We everytime develop and adopt the safest strategies.

 

 


      Cancer is not overcome by a single therapy but mixed einsamble therapies will be effective for individuals.

Cancer cells are defined as in the state of unregulatedly abnormal growth.  Growth signal tranducing, transcriptional, apoptotic factors, so far are engaging in the control of the cell growth.  Cancer initiation may occur when DNA is damaged by radical oxygeon species (ROS) followed by DNA mutation, deletions. These improperly repaired DNAs induce ultimate trancriptional abnormality to cancers.  Genetic abnormalities of RAS, PI3K, p53 and others in the cancer cells are frequently found. There are also found overexpression of growth promotive RAS,RAF,MEK,ERK pathway and/or overexpression of PI3K, AKT pathway, by inhibiting tumor suppressive TSC1/2 which drive mTORC1 to cell growth. These cancer driving pathways are stopped by gene targeting and inhibitors contained in herbs. Aside from abnormal cell growth and signaling factors, cancer cells are recognized and excluded by immune cells. NK cells distinguish cancer cells from normal cells by self-missing which lost MHC-I and by sensoring with KAR/KIR.  KAR mainly recognize tumor markers, while KIR does MHC-I.  NKG2DLs comprise MICA/B and UL16.NKG2D–NKG2DL stimulation of NK cells leads to strong activation and tumor cell rejection.7NKT cells are activated by CD1d of dendritic (DC) cells and produce abundant of Th1 of cytokines, such as γ-interferon. DC and macrophages phagocyte cancer cells and present cancer antigens to be recognized by CD4+Tcells. CD4+Tcells activates CD8+Tcells(Cytotoxic CTL) which kill cancer cells. Cancer is caused in immuno compromised atate and our immune cell-therapy using ensemble cells is effective for various cancers.

Dr Masanobu Chinami : ReferenceROS and not properly repaired.

Adoptive immue cell therapy

Monocytes are collected from patients and dendrocytets (DC) cells and other cells including NKT cells are separated. DC is pulsed with cancer antigens for education and cultured with other cells for infusion to the patients. Chinami et.al:Case Report: Assessment by miRNA microarray of an Autologous Cancer Antigen-pulsed Adoptive Immune Ensemble Cell Therapy (AC-ACT) approach; demonstrated induction of anti-oncogenic and anti-PD-L1 miRNAs.

Gnene targeting therapy

Antioncogenes and anti-sense against oncogenes are introduced by plasmid vectors. They are not integrated into host chromosome and not sel-replicate, thus  give no cancer risks.

Herbal supplements

Precision or Personalized Medicine for Cancer Chemotherapy is proposed. polyphenol molecules are . 


clnical specimen: Monocytes collected from 20ml of blood are sent and cultured.

 

The procedures for preparing the samples were performed within a high efficiency particle arrestance (HEPA)-filter clean-air barriered good manufacturing practice (GMP) cell processing facility.  A standard operation procedure (SOP) for the production was established according to institutional GMP-based guidelines.

Staffs

CEO: Masanobu Chinami, MD&PhD ; aciam@crux@ocn.ne.jp

Research Director: Chaker N. Adra,PhD(left picture); cnadra@crux@ocn.ne.jp; (Ref:https://www.ncbi.nlm.nih.gov/pubmed/?term=Adra+CN)

Research Director:Kaoru Iwabuchi, PhD

Reserch associate:Miki Nakashima

Excellent works done by Chaker Adra

(1) Pregnenolone sulfate “The Brain Steroid”, one of steroid metabolites was found to be effective for Alzheimer and other neurodegenerative disease (1). Steroids have many effects such as anti-inflammatory, immune-suppressive effects, and so far. This formula of compound specifically enter into nAdra CN, Zhu S, Ko JL, Guillemot JC, Cuervo AM, Kobayashi H, Horiuchi T, Lelias JM, Rowley JD, Lim B. LAPTM5: A novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics. 1996;35:328–337. euronal cell and give effects to the cells.
(2) αB-crystallin, one of heat shock proteins, when used at severe burn, was found to have remarkable effects of suppression SIRS (systemic inflammatory response syndrome) and rescue lives of mice (2).  Spraying of αB-crystalline proteins in cases of severe burn has a possibility of great improvement for rescue rate in human and other farm animals.
(3) SMARCAD1, a human helicase gene was cloned (3 al.Genomics. 2000 ) and this is highlighted as “finger print gene” and also  (4,5 Nature. 2012 )
(4) HTm4 gene was cloned (6 Proc Natl Acad Sci U S A. 1994 ). This is similar to IgEFcεRIβ which is associated with allergy and atopic diseases and also cycle regulation (7J Biol Chem. 2005)
(5) Promotor gene of PGK1(phosphoglycerate kinase1 ) was cloned (8 Gene 1987) and this is widely used for gene therapy as (pgk1)-Neo Cassette/Shuttl (9 J. Virol. 1996)
(6) PGK2 gene was found to exist specifically in the testis autosomal chromosome (10 . Mol Cell Biol. 1987). This gene has no introns different from PGK1, which demonstrates PGK2 evolved in the very old time by retrotransposon afterbarising from PGK1.

(7)  LAPTM5: A novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics. 1996;35:328–337. Adra et.al


clnical specimen: Monocytes collected from 20ml of blood are sent and cultured.

 

The procedures for preparing the samples were performed within a high efficiency particle arrestance (HEPA)-filter clean-air barriered good manufacturing practice (GMP) cell processing facility.  A standard operation procedure (SOP) for the production was established according to institutional GMP-based guidelines.

Staffs

CEO: Masanobu Chinami, MD&PhD ; aciam@crux@ocn.ne.jp

Research Director: Chaker N. Adra,PhD(left picture); cnadra@crux@ocn.ne.jp; (Ref:https://www.ncbi.nlm.nih.gov/pubmed/?term=Adra+CN)

Research Director:Kaoru Iwabuchi, PhD

Reserch associate:Miki Nakashima

Excellent works done by Chaker Adra

(1) Pregnenolone sulfate “The Brain Steroid”, one of steroid metabolites was found to be effective for Alzheimer and other neurodegenerative disease (1). Steroids have many effects such as anti-inflammatory, immune-suppressive effects, and so far. This formula of compound specifically enter into nAdra CN, Zhu S, Ko JL, Guillemot JC, Cuervo AM, Kobayashi H, Horiuchi T, Lelias JM, Rowley JD, Lim B. LAPTM5: A novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics. 1996;35:328–337. euronal cell and give effects to the cells.
(2) αB-crystallin, one of heat shock proteins, when used at severe burn, was found to have remarkable effects of suppression SIRS (systemic inflammatory response syndrome) and rescue lives of mice (2).  Spraying of αB-crystalline proteins in cases of severe burn has a possibility of great improvement for rescue rate in human and other farm animals.
(3) SMARCAD1, a human helicase gene was cloned (3 al.Genomics. 2000 ) and this is highlighted as “finger print gene” and also  (4,5 Nature. 2012 )
(4) HTm4 gene was cloned (6 Proc Natl Acad Sci U S A. 1994 ). This is similar to IgEFcεRIβ which is associated with allergy and atopic diseases and also cycle regulation (7J Biol Chem. 2005)
(5) Promotor gene of PGK1(phosphoglycerate kinase1 ) was cloned (8 Gene 1987) and this is widely used for gene therapy as (pgk1)-Neo Cassette/Shuttl (9 J. Virol. 1996)
(6) PGK2 gene was found to exist specifically in the testis autosomal chromosome (10 . Mol Cell Biol. 1987). This gene has no introns different from PGK1, which demonstrates PGK2 evolved in the very old time by retrotransposon afterbarising from PGK1.

(7)  LAPTM5: A novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics. 1996;35:328–337. Adra et.al


Tinami Cancer Clinic

Etsuji 292, Kasuyamachi, 811-2313 Fukuoka Japan

TEL : 092-405-8216, tinamim1@dia-net.ne.jp

 

 

Tinami Cancer Clinic

Etsuji 292, Kasuyamachi, 811-2313 Fukuoka Japan

TEL : 092-405-8216, tinamim1@dia-net.ne.jp